ABSTRACT With the use of equilibrium radionuclide ventriculography the effects on left ventricular (LV) function of 160 mg oral propranolol daily and 360 mg verapamil daily alone and in combination were compared in 18 patients with chronic exertional angina. A randomized, double-blind, placebocontrolled, crossover protocol was used. The reduction in exercise rate-pressure product induced by the combination (1 18 ± 28 mm Hg/min) was significantly greater (p < .05) than that by propranolol (135 + 27 mm Hg/min) or verapamil alone (163 ± 28 mm Hg/min). In patients at rest, neither single nor combined therapy altered global or regional left ventricular ejection fractions (EFs). Verapamil, but not propranolol, increased (p < .05) cardiac volumes of resting subjects; used in combination, no further increase in LV volume occurred. With placebo, exercise global EF did not decrease from the level at rest and therefore no drug effect could be demonstrated for this parameter of LV function. By an evaluation of normalized regional EF measurements the combination was shown to reduce exerciseinduced hypokinesis (placebo 52 ± 20%, combination 61 + 23%; p < .01). No significant improvement was noted with propranolol or verapamil alone; only the combination prevented a significant increase in end-systolic and end-diastolic volumes during exercise. Thus, propranolol and verapamil, used alone in moderate doses, exert no beneficial effect on exercise LV function as measured by EF and volume changes, and resting function deteriorates slightly with verapamil. Compared with single-drug therapy, the combination causes no further change in LV function of resting subjects and improves exercise function. This improvement was most likely due to a reduction in myocardial oxygen demand. Circulation 68, No. 6, 1280No. 6, -1289No. 6, , 1983 COMBINATION THERAPY with /8-adrenergic-receptor antagonists and nitrates is a well-established part of the treatment of chronic exertional angina. Recently, reports have shown that calcium-channel antagonists such as verapamil have antianginal properties comparable to those of propranolol.'-1 Moreover, in selected patients, the combination of propranolol and
apamil has another mechanism of action that is responsible for its beneficial effect in patients with exertional angina. Both a coronary artery vasodilatory action" and improvement in diastolic filling properties have been suggested.'2 Unfortunately, since both drugs exert significant negative inotropic and chronotropic effects, concern has arisen regarding the adverse effects of fl-blockade and calcium-antagonist combination therapy. '3, 14 At the present time, limited data are available concerning left ventricular performance, and in particular left ventricular volume changes associated with combined oral fl-receptor blockade and calcium-antagonist therapy over a prolonged period. Data obtained from short-term invasive studies have revealed additive cardiodepressant effects. 15 16 Although the significance of these changes remains controversial, it is generally accepted that caution should be exercised when the combination is used in the presence of left ventricular dysfunction. Accordingly, our study was undertaken to determine what, if any, detrimental effects therapy with the combination of oral propranolol and verapamil had on the left ventricular function of resting and exercising subjects. Several radionuclide variables were examined to help clarify the mechanism by which these drugs exert their actions.
Methods
Patient population. Nineteen men and one woman, 38 to 73 years old (mean 57), with Canadian Cardiovascular Society functional class II or III stable exertional angina were studied. While off all antianginal medication, patients experienced two or more episodes of exertional angina per week and during treadmill exercise they had an ischemic electrocardiographic response (horizontal or downsloping ST segment depression of at least 1 mm). All patients had to terminate treadmill exercise due to angina. Patients were in sinus rhythm with a PR interval 60.20 sec in duration and a QRS complex width of 0. 12 sec. Six patients had a history of a remote myocardial infarction (¢6 months). Fourteen patients had undergone coronary angiography within year of the study and all had significant coronary artery disease (defined as >50% diameter vessel narrowing). Three, four, and seven patients had one-, two-, and three-vessel coronary artery disease, respectively. Two patients previously underwent coronary artery bypass surgery. In no patient was there clinical evidence of hypertension, valvular heart disease, chronic obstructive lung disease, or heart failure. Three patients had radionuclide evidence of left ventricular dysfunction with reduced ejection fractions of 22%, 28%, and 48%. Patients from the outpatient department and in-hospital population were assessed in a consecutive manner and those meeting entry criteria were included in the study.
Study design (figure 1 Radionuclide ventriculography. Electrocardiographic multigated equilibrium radionuclide ventriculography was performed with the patient in the supine position to assess left ventricular function and volume at rest and during submaximal and maximal exercise. After in vivo labeling of red blood cells with 20 mCi of technetium-99m pertechnetate, cardiac scintigraphy was performed with patients in the left anterior oblique position that best isolated the left ventricle. A study to obtain resting values was performed after the patient's legs were elevated for at least 2 min. All images were collected for 2 min with a conventional Anger scintillation camera equipped with a high-sensitivity parallel-hole collimator interfaced to a dedicated medical computer system. 7 Left ventricular volumes were calculated by a count-based, nongeometric method without individual attenuation correction that was modified from that described by others. '9 " Background-corrected end-diastolic and end-systolic regions of interest were generated as described for the calculation of global ejection fraction. End-systolic and end-diastolic volumes were derived from the count measurements and normalized for counts per milliliter of peripheral venous blood. As in an earlier study,2' we demonstrated in our preliminary experiments a significant increase in radioactive-tracer concentration during successive stages of exercise. This necessitated withdrawal of 3 ml of peripheral venous blood from patients at rest and midway through the exercise period. By this method, the correlation coefficient for contrast and radionuclide ventriculography in 28 previously studied patients was .95 (SEE = 22.5 ml) for enddiastolic volume and .97 (SEE = 17.2 ml) for end-systolic volume.
Twenty-three normal subjects who were a mean 55 years old (range 41 patients who entered the study, two withdrew after randomization to therapy. One patient developed symptomatic bradycardia while taking the combination and the other developed a skin rash while taking verapamil. The most conmmon side effects were fatigue with propranolol (two patients) and constipation with verapamil (five patients); these same symptoms usually recurred when the drugs were taken in combination. Three patients developed evidence of heart failure characterized by the presence of symptoms, mainly dyspnea, or pulmonary vascular congestion on chest xray during combination therapy. One of these patients also complained of dyspnea while on propranolol. Of these three patients, two had significant decreases in their resting ejection fractions (from 48% to 42% and from 65% to 59%). The patient who developed heart CIRCULATION failure on both propranolol alone and the combination had a rise in resting ejection fraction from 22% with placebo to 29% with propranolol and to 27% with the combination. End-systolic and end-diastolic volumes increased significantly in all four instances, but the increases were no greater than those noted in patients who did not complain of dyspnea. Three patients reported orthostatic dizziness during combination therapy. Four patients developed asymptomatic first-degree atrioventricular block while on the combination. Thirteen patients experienced angina during supine exercise after placebo and propranolol, and 11 and nine had angina after verapamil and the combination, respectively. Review of patient diaries revealed slight but insignificant reductions in the number of angina attacks and in nitroglycerin consumption with all treatments.
Heart rate, blood pressure, and electrocardiographic changes ( 30 Observation of changes in cardiac volumes, particularly end-systolic volume and the PSP/ESVI ratio. In this study, a significant improvement in exercise-induced hypokinesis occurred only with the combination therapy and this beneficial effect was associated with a significant reduction in ratepressure product compared with after propranolol alone. In addition, at an equivalent rate-pressure product hypokinetic segment function was similar with placebo and the combination. This finding supported work by Leon et al.,4 who suggested that the primary mechanism of action of the combination was to reduce myocardial oxygen demand. Exercise-induced ischemia, in addition to depressing exercise global ejection fraction, may also cause an increase in end-systolic volume.5" Our study demonstrated a highly significant increase in end-systolic volume in patients taking placebo. Although this was limited to some extent by propranolol and verapamil, only the combination prevented a significant increase. This finding, together with the observed effect on exercise hypokinetic segments, clearly demonstrated the beneficial anti-ischemic properties of the combination.
The relationship between left ventricular ejection fraction and volumes and symptoms of heart failure has not been established. Calculation of these parameters in our study did not aid in identifying those patients who developed clinical evidence of drug-induced heart failure. Others have shown a direct correlation between radionuclide-derived end-diastolic volume and pulmonary capillary wedge pressure, suggesting that an increase in end-diastolic volume may be observed in the presence of drug-induced pulmonary edema.5' Although in our study end-systolic and enddiastolic volumes increased in all patients who became dyspneic, these changes were not significantly different from those noted in patients who did not to a concomittent increase in end-diastolic volume. Similarly, during exercise a highly significant increase in end-systolic volume occurred with placebo and single-drug therapy, and it occurred without a reduction in global ejection fraction. Thus, this parameter was not helpful in detecting the beneficial effect of the combination therapy on exercise left ventricular function. The failure to observe a significant decrease in exercise ejection fraction during placebo administration cannot be readily explained. A greater ischemic response would presumably increase end-systolic volume further, causing a reduction in ejection fraction. End-systolic volume may be a more sensitive indicator of ischemia and subsequent drug effect.
The effect of verapamil on normal exercise left ventricular function has not been previously described. By observing normokinetic segment function, our data would suggest that verapamil depresses normal exercise ventricular function. Also, assessment of normokinetic segment function permitted further understanding of the global ejection fraction response. For example, although the combination depressed exercise normokinetic segment function, exercise global ejection fraction did not fall below the exercise placebo value because of improvement in exercise-induced hypokinesis.
In conclusion, combination therapy with propranolol and verapamil in patients with exertional angina and normal or near-normal left ventricular function is not associated with worsening of resting systolic function when compared with single-drug therapy. Moreover, only the combination significantly improves exercise left ventricular function, and in doing so it is associated with an additional decrease in the rate-pressure product, which implies a reduction in myocardial oxygen demand. Although this combination therapy improves exercise left ventricular function it should be used with caution because of the potential for adverse effects. 
